Web Results

en.wikipedia.org/wiki/GlaxoSmithKline

Pharmaceuticals[edit]. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. Its biggest-selling products in 2013 were Advair, Avodart, Flovent, Augmentin, Lovaza, and Lamictal ; its drugs and vaccines earned £21.3 billion that ...

en.wikipedia.org/wiki/GlaxoSmithKline_Pharmaceuticals_Ltd

GlaxoSmithKline Pharmaceuticals Ltd (BSE: 500660 NSE: GSKCONS) is an Indian subsidiary of GlaxoSmithKline plc, one of the world's leading research based pharmaceutical and healthcare companies. It is one of the oldest pharmaceuticals companies in India. It product portfolio includes prescription medicines and ...

www.gsk.com

The homepage of the GSK global corporate website.

us.gsk.com

GSK - our mission is to help people do more, feel better, and live longer.

www.gsk.com/en-gb/careers

We are a global company delivering billions of healthcare products a year. Choose your path.

www.linkedin.com/company/glaxosmithkline

About us. A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high- quality ...

economictimes.indiatimes.com/glaxosmithkline-pharmaceuticals-ltd/stocks/companyid-13715.cms

GlaxoSmithKline Pharmaceuticals Share Price Today, GlaxoSmithKline Pharmaceuticals Stock Price, GlaxoSmithKline Pharmaceuticals BSE/NSE Live Share Price, Stock Performance, Stock Quotes, Charts & more on The Economic Times.

profit.ndtv.com/stock/glaxosmithkline-pharmaceuticals-ltd_glaxo

Glaxosmithkline Phar Share Price, Glaxosmithkline Phar Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Glaxosmithkline Phar, Glaxosmithkline Phar News, Videos, Stock Market Reports, capitalisation, financial report, volume, market performance, company results information, balance sheet and ...

www.moneycontrol.com/company-facts/glaxosmithklinepharmaceuticals/dividends/GSK

For the year ending March 2017, GlaxoSmithKline Pharmaceuticals has declared an equity dividend of 500.00% amounting to Rs 50 per share. At the current share price of Rs 2469.95 this results in a dividend yield of 2.02%. The company has a good dividend track report and has consistently declared dividends for the last ...